BeOne Medicines: Brukinsa's Leadership And Royalty Sale Signal A Stronger Future (NASDAQ:ONC)

BeOne's BRUKINSA leads in liquid cancers, fueling growth with reduced legal risks, strong cash flow, and R&D prospects. Learn more on ONC stock here.